Prostaid Calgary hosts Dr. Fedir Razumenko at their support group meeting on November 19th for a discussion on the history ...

Researchers at the University of Southampton have identified a new subtype of lymphoma which could pave the way to improved ...

A national quality improvement program led by the American College of Surgeons (ACS) found that transportation barriers and illness are among the top reasons cancer patients miss critical radiation ...

The Australian Government today launched the National Cancer Data Framework, marking a major step forward in improving ...

Canadians now have access to a public listing of active cancer clinical trials across the country, a resource that’s long ...

A Gov.uk statement warns: "Formaldehyde has been classified as a cancer causing chemical in humans by the International ...

This substance is found in some disinfectants and air fresheners and has been designated as a human carcinogen by the ...

DWTX READ THE FULL DWTX RESEARCH REPORT Business Update 100 Patients Enrolled in Phase 2b Trial of Halneuron®; Interim ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

CHS-114, a highly selective Treg depleter, clinical program expanded to include colorectal cancer –– Q3 2025 ending cash, cash equivalents and ...

Amtagvi monotherapy achieved a 25.6% objective response rate and 71.8% disease control rate in NSCLC patients without ...

Recall, at the 2025 SNO/ASCO CNS Metastases conference in August, ReSPECT-LM Phase 1 single dose escalation trial data showed: REYOBIQ produced a clinical benefit rate of over 75% in 3 clinically ...